vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Sprinklr, Inc. is the larger business by last-quarter revenue ($219.1M vs $127.1M, roughly 1.7× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 9.2%). Sprinklr, Inc. produced more free cash flow last quarter ($19.8M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

CXM vs ZLAB — Head-to-Head

Bigger by revenue
CXM
CXM
1.7× larger
CXM
$219.1M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+8.0% gap
ZLAB
17.1%
9.2%
CXM
More free cash flow
CXM
CXM
$46.5M more FCF
CXM
$19.8M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
ZLAB
ZLAB
Revenue
$219.1M
$127.1M
Net Profit
$2.9M
Gross Margin
66.4%
51.0%
Operating Margin
5.3%
-54.6%
Net Margin
1.3%
Revenue YoY
9.2%
17.1%
Net Profit YoY
-72.2%
EPS (diluted)
$0.01
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
ZLAB
ZLAB
Q4 25
$219.1M
$127.1M
Q3 25
$212.0M
$115.4M
Q2 25
$205.5M
$109.1M
Q1 25
$202.5M
$105.7M
Q4 24
$200.7M
$108.5M
Q3 24
$197.2M
$101.8M
Q2 24
$196.0M
$100.1M
Q1 24
$194.2M
$87.1M
Net Profit
CXM
CXM
ZLAB
ZLAB
Q4 25
$2.9M
Q3 25
$12.6M
$-36.0M
Q2 25
$-1.6M
$-40.7M
Q1 25
$98.7M
$-48.4M
Q4 24
$10.5M
Q3 24
$1.8M
$-41.7M
Q2 24
$10.6M
$-80.3M
Q1 24
$21.1M
$-53.5M
Gross Margin
CXM
CXM
ZLAB
ZLAB
Q4 25
66.4%
51.0%
Q3 25
68.2%
59.5%
Q2 25
69.5%
60.6%
Q1 25
71.0%
63.6%
Q4 24
71.2%
61.5%
Q3 24
72.6%
64.1%
Q2 24
73.9%
64.9%
Q1 24
75.5%
61.4%
Operating Margin
CXM
CXM
ZLAB
ZLAB
Q4 25
5.3%
-54.6%
Q3 25
7.7%
-42.3%
Q2 25
-0.9%
-50.3%
Q1 25
5.2%
-53.3%
Q4 24
3.9%
-62.6%
Q3 24
-0.0%
-66.6%
Q2 24
2.9%
-76.0%
Q1 24
9.5%
-80.7%
Net Margin
CXM
CXM
ZLAB
ZLAB
Q4 25
1.3%
Q3 25
5.9%
-31.2%
Q2 25
-0.8%
-37.3%
Q1 25
48.7%
-45.8%
Q4 24
5.2%
Q3 24
0.9%
-40.9%
Q2 24
5.4%
-80.2%
Q1 24
10.9%
-61.4%
EPS (diluted)
CXM
CXM
ZLAB
ZLAB
Q4 25
$0.01
$-0.05
Q3 25
$0.05
$-0.03
Q2 25
$-0.01
$-0.04
Q1 25
$0.35
$-0.04
Q4 24
$0.04
$-0.09
Q3 24
$0.01
$-0.04
Q2 24
$0.04
$-0.08
Q1 24
$0.07
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$189.6M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$558.1M
$715.5M
Total Assets
$1.1B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
ZLAB
ZLAB
Q4 25
$189.6M
$689.6M
Q3 25
$125.4M
$717.2M
Q2 25
$126.4M
$732.2M
Q1 25
$145.3M
$757.3M
Q4 24
$93.2M
$779.7M
Q3 24
$119.1M
$616.1M
Q2 24
$126.8M
$630.0M
Q1 24
$164.0M
$650.8M
Stockholders' Equity
CXM
CXM
ZLAB
ZLAB
Q4 25
$558.1M
$715.5M
Q3 25
$543.4M
$759.9M
Q2 25
$639.8M
$791.7M
Q1 25
$612.1M
$810.8M
Q4 24
$497.0M
$840.9M
Q3 24
$469.0M
$667.7M
Q2 24
$610.9M
$704.2M
Q1 24
$679.7M
$762.2M
Total Assets
CXM
CXM
ZLAB
ZLAB
Q4 25
$1.1B
$1.2B
Q3 25
$1.1B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.2B
$1.2B
Q4 24
$970.3M
$1.2B
Q3 24
$983.8M
$985.3M
Q2 24
$1.1B
$987.4M
Q1 24
$1.2B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
ZLAB
ZLAB
Operating Cash FlowLast quarter
$20.0M
$-26.0M
Free Cash FlowOCF − Capex
$19.8M
$-26.7M
FCF MarginFCF / Revenue
9.0%
-21.0%
Capex IntensityCapex / Revenue
0.1%
0.5%
Cash ConversionOCF / Net Profit
6.87×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
ZLAB
ZLAB
Q4 25
$20.0M
$-26.0M
Q3 25
$34.8M
$-32.0M
Q2 25
$83.8M
$-31.0M
Q1 25
$5.4M
$-61.7M
Q4 24
$9.2M
$-55.8M
Q3 24
$21.3M
$-26.8M
Q2 24
$41.7M
$-42.2M
Q1 24
$17.3M
$-90.1M
Free Cash Flow
CXM
CXM
ZLAB
ZLAB
Q4 25
$19.8M
$-26.7M
Q3 25
$34.4M
$-35.0M
Q2 25
$83.5M
$-33.9M
Q1 25
$4.6M
$-63.2M
Q4 24
$8.2M
$-58.4M
Q3 24
$19.8M
$-28.2M
Q2 24
$39.2M
$-42.9M
Q1 24
$15.2M
$-91.1M
FCF Margin
CXM
CXM
ZLAB
ZLAB
Q4 25
9.0%
-21.0%
Q3 25
16.2%
-30.4%
Q2 25
40.6%
-31.1%
Q1 25
2.3%
-59.9%
Q4 24
4.1%
-53.8%
Q3 24
10.1%
-27.7%
Q2 24
20.0%
-42.9%
Q1 24
7.9%
-104.5%
Capex Intensity
CXM
CXM
ZLAB
ZLAB
Q4 25
0.1%
0.5%
Q3 25
0.2%
2.6%
Q2 25
0.1%
2.6%
Q1 25
0.4%
1.5%
Q4 24
0.5%
2.4%
Q3 24
0.8%
1.3%
Q2 24
1.3%
0.7%
Q1 24
1.1%
1.1%
Cash Conversion
CXM
CXM
ZLAB
ZLAB
Q4 25
6.87×
Q3 25
2.76×
Q2 25
Q1 25
0.05×
Q4 24
0.88×
Q3 24
11.58×
Q2 24
3.92×
Q1 24
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons